(₹ crores) | Q1FY26 | Q4FY25 | Q1FY25 | QoQ (%) | YoY (%) |
---|---|---|---|---|---|
Total Income | 196.93 | 170.62 | 177.55 | 15.4% | 10.9% |
Total Expenses | 169.51 | 148.02 | 154.35 | 14.5% | 9.8% |
Profit Before Tax | 27.41 | 22.60 | 23.20 | 21.3% | 18.1% |
Tax | 6.90 | 3.88 | 5.28 | 77.8% | 30.7% |
Profit After Tax | 20.52 | 18.73 | 17.92 | 9.6% | 14.5% |
Earnings Per Share | 6.30 | 5.70 | 5.50 | 10.5% | 14.5% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Krsnaa Diagnostics Ltd operates within the healthcare industry, primarily focusing on diagnostic services. The company provides a range of diagnostic services, including radiology, pathology, and tele-radiology, catering to both individuals and healthcare institutions. Krsnaa Diagnostics is known for establishing diagnostic centers across multiple locations, aiming to offer accessible and affordable healthcare diagnostics. As of the latest information, there are no specific recent major developments available for Krsnaa Diagnostics Ltd.
In the first quarter of fiscal year 2026 (Q1FY26), Krsnaa Diagnostics Ltd reported a total income of ₹196.93 crores. This represents a quarter-over-quarter (QoQ) growth of 15.4% from the ₹170.62 crores recorded in the fourth quarter of fiscal year 2025 (Q4FY25). Additionally, the year-over-year (YoY) growth stands at 10.9% compared to the ₹177.55 crores reported in the first quarter of fiscal year 2025 (Q1FY25). The upward trend in revenue indicates an increase in the company's business activities over the past year and quarter.
The company's profitability, as measured by the profit before tax (PBT), reached ₹27.41 crores in Q1FY26. This reflects a significant QoQ increase of 21.3% from ₹22.60 crores in Q4FY25, and an 18.1% YoY increase from ₹23.20 crores in Q1FY25. After accounting for taxes, the profit after tax (PAT) for Q1FY26 was ₹20.52 crores, showing a 9.6% QoQ growth from ₹18.73 crores in Q4FY25 and a 14.5% YoY increase from ₹17.92 crores in Q1FY25. Earnings per share (EPS) mirrored this growth with a value of ₹6.30 in Q1FY26, up 10.5% QoQ from ₹5.70 and 14.5% YoY from ₹5.50.
In terms of expenses, Krsnaa Diagnostics Ltd reported total expenses of ₹169.51 crores for Q1FY26. This marks a 14.5% increase QoQ from ₹148.02 crores in Q4FY25 and a 9.8% rise YoY from ₹154.35 crores in Q1FY25. The company's tax expense also rose significantly by 77.8% QoQ to ₹6.90 crores in Q1FY26, compared to ₹3.88 crores in Q4FY25, and by 30.7% YoY from ₹5.28 crores in Q1FY25. These metrics highlight the company's operational expenditure and tax obligations over the reported periods.
Krsnaa Diagnostics Ltd announced its Q1 FY 2025-26 results on 12 August, 2025.
Krsnaa Diagnostics Ltd quarterly results refer to the company’s financial performance over a three-month period, including key metrics like revenue, net profit, earnings per share (EPS), and margin performance.
Key highlights of Krsnaa Diagnostics Ltd Q1 FY 2025-26 results include:
Krsnaa Diagnostics Ltd reported a net profit of ₹20.52 crore in Q1 FY 2025-26, reflecting a 14.5% year-over-year growth.
Krsnaa Diagnostics Ltd posted a revenue of ₹196.93 crore in Q1 FY 2025-26.